TP53 and cancer: For instance, ATM and/or ATR activate the tumor suppressor protein p53, which is known to be mutated in most cancers, in order to promote cell cycle arrest (p21 activation) or apoptosis (BAX-mediated caspase-3 cleavage) [34].